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Congenital ocular colobomas are tissue defects which occur as a result of failure of the 
ectodermal optic vesicle fissure to close at around 5-7 weeks of fetal life.1 These defects can 
affect one or more ocular structures including the iris, ciliary body, lens, retina, choroid, and 
optic nerve. The incidence of WHO defined blindness (<3/60 best corrected vision in the better 
eye) has been reported as low as 7% in simple ocular coloboma to 66% in eyes with ocular 
coloboma and microphthalmos.2 Most cases are sporadic, but may be familial, in which case 
autosomal dominant inheritance is most common. Ocular colobomas occur in a variety of 
chromosomal abnormalities and syndromic disorders. Recently, Williamson et al. identified a 
heterozygous nonsense mutation in YAP1 in a family with isolated ocular coloboma.3 We 
describe a further family with isolated ocular coloboma associated with a YAP1 mutation where 
there is evidence of incomplete penetrance. 
 
A 20-year-old male (patient 1) presented with a history of visual impairment since birth. He had 
been diagnosed with iris and retinal colobomas in each eye at a young age. His medical history 
was otherwise unremarkable and there were no systemic abnormalities. On examination, his best 
corrected visual acuities (BCVA) were 20/200 with no pinhole improvement in the right eye and 
20/200 with pinhole improvement to 20/125 in the left eye. After 3 years of follow-up, BCVA 
had deteriorated to hand movements in the right eye and 20/400 in the left. He had bilateral 
inferonasal iris colobomas (Figure 1A). On dilated examination, he had bilateral large inferior 
chorioretinal colobomas encompassing the discs (Figure 1A). There was a shallow area of 
subretinal fluid in the left eye in the region of the coloboma and immediate adjacent temporal 
retina. Optical coherence tomography revealed fluid beneath residual glial tissue in the area of 
the left chorioretinal coloboma (Figure 1A). There was a marginal increase in fluid after 3 years 
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in the left eye only. Patient 2, the maternal half-brother of patient 1, is a 12-year-old boy who 
had no visual symptoms with refractive correction, but did notice his right eye was smaller than 
his left. His medical history was otherwise unremarkable and there were no other systemic 
abnormalities. On examination, his BCVA was 20/20 in each eye. He had bilateral inferior 
retinal colobomas and bilateral optic disc colobomas (Figure 1B). The mother of the two boys 
was one of four children born to unaffected, unrelated parents. She had normal visual acuity and 
a normal fundus examination. Patient 2’s sister (patient 1’s maternal half sister) also had a 
normal examination.  
 
DNA samples of both patients underwent whole exome sequencing (WES, AROS Applied 
Biotechnology, Aarhus, Denmark) using the Illumina TruSeq exome capture kit and the Illumina 
HiSeq 2000 sequencer (Illumina Inc.). There were no shared homozygous, X-linked or 
compound heterozygous rare (MAF<0.001) variants. There were 54 shared, rare heterozygous 
variants of which only 1 arose in a gene implicated in coloboma, YAP1 (Yes-associated-protein 
1, MIM#606608). Sanger sequencing confirmed the heterozygous mutation c.284T>C (p.F95S) 
in both affected half brothers as well as in their unaffected mother (Figure 2). This mutation is 
absent from all variant databases (dbSNP, 1kgenome, EVS and ExAC), affects an amino acid 
highly conserved across a diverse range of species (Figure 2), and had equivocal pathogenic 
predictions in silico (Sift 0.04 damaging, Polyphen2 0.085 tolerated). Mutation nomenclature 
was assigned in accordance with GenBank Accession number NM_001130145.2, with 
nucleotide position 1 corresponding to the A of the ATG translation initiation codon. There was 
no evidence of mosaicism for this mutation in the peripheral-blood-derived DNA from the 
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mother (Figure 2). No other tissues were available from the mother nor DNA from other family 
members for further study. 
 
This report describes a novel mutation in YAP1 associated with isolated ocular coloboma in a 
family with an autosomal dominant pattern of inheritance with apparent incomplete penetrance. 
Unaffected mutation carriers have been described previously in families with autosomal 
dominant coloboma including one family with a YAP1 mutation reported by Williamson et al.3 It 
is unclear whether this represents true incomplete penetrance or germ line mosaicism. Similar 
mutation carriers with a normal ocular phenotype have been reported in families with 
anophthalmos/microphthalmos associated with mutations in OTX2 and SOX 2.4,5 
  
The YAP (Yes-associated-protein) gene was originally characterized by Sudol et al. who 
identified a regulatory protein responsible for protein-protein interactions with ubiquitous 
expression at the RNA level,6 later shown to be associated with the Hippo signaling pathway 
responsible for cell contact inhibition integral in the control of organ size during development.7 
Using in situ hybridization and immunohistochemistry, Williamson et al. observed expression of 
YAP1 in the otic vesicle and future brainstem at 9.5 days postconception which continued as 
strong expression on the distal optic cup, suggesting that the protein is present in the developing 
lens and optic stalk.5 This same group also identified different heterozygous nonsense mutations 
in YAP1 in a family with isolated ocular coloboma, and in another family with ocular coloboma 
and variable multisystem involvement (hearing loss, intellectual disability, hematuria, and 
orofacial clefting). In the first family, apparent non-penetrance was identified in an unaffected 
carrier similar to the mother in this report. They additionally identified 4 families with 
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heterozygous missense variants in YAP1 all thought to be non-pathogenic. In one family, this 
was based on non-segregation with disease. In the other 3 families, the identified mutations arose 
in residues that were not evolutionarily conserved when compared with mouse, chick and 
zebrafish. Phenylalanine-95 in this study is highly conserved across all 9 species analyzed 
including mouse, chick and zebrafish (Figure 2). This study supports the idea that mutations 
affecting only the long transcript (those occurring before Met179 of NM_001130145.2) might 
give rise to the localized ocular phenotype, while those that affect both long and short transcripts 
(after Met179) might cause a multi-system disorder. 
 
To date, only two families with coloboma have been reported with mutations in YAP1 gene, a 
gene with known strong expression in developing ocular structures and known to have a role in 
cell proliferation during organogenesis. Here, we report a third family with autosomal dominant 
coloboma with a novel heterozygous mutation in YAP1 and confirm that mutations in this gene 
may be associated with incomplete penetrance, or germ line mosaicism a well recognized feature 
of autosomal dominant coloboma. 
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FIGURE 1. Color fundus image montages, fundus autofluorescence imaging (FAF) and optical 
coherence tomography (OCT) of patient 1 (A) and color fundus image montages of patient 2 (B). 
Images of the left eye of patient 1 show fluid under residual glial tissue confined to the left 
chorioretinal coloboma 
 
 
 
FIGURE 2. A. Chromatograms from Sanger sequencing for patients 1, 2, and their mother. B. 
Family pedigree (family GC20086) with YAP1 segregation. C. Conservation across species, 
generated by Clustal Omega. * (asterisk) indicates positions which have a single, fully conserved 
residue, a : (colon) indicates conservation between groups of strongly similar properties, a . 
(period) indicates conservation between groups of weakly similar properties. 
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